Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Legend Biotech Corp ADR (LEGN)

Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,317,723
  • Shares Outstanding, K 182,305
  • Annual Sales, $ 285,140 K
  • Annual Income, $ -518,250 K
  • EBIT $ -170 M
  • EBITDA $ -149 M
  • 60-Month Beta 0.11
  • Price/Sales 24.55
  • Price/Cash Flow N/A
  • Price/Book 6.11

Options Overview Details

View History
  • Implied Volatility 65.96% ( +5.30%)
  • Historical Volatility 47.56%
  • IV Percentile 85%
  • IV Rank 46.16%
  • IV High 105.05% on 07/12/24
  • IV Low 32.45% on 12/20/23
  • Put/Call Vol Ratio 0.18
  • Today's Volume 321
  • Volume Avg (30-Day) 589
  • Put/Call OI Ratio 1.27
  • Today's Open Interest 12,227
  • Open Int (30-Day) 15,466

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.31
  • Number of Estimates 9
  • High Estimate -0.13
  • Low Estimate -0.60
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +22.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.92 +8.72%
on 11/19/24
47.79 -16.01%
on 11/05/24
-2.73 (-6.37%)
since 10/18/24
3-Month
36.92 +8.72%
on 11/19/24
59.62 -32.67%
on 09/03/24
-16.92 (-29.65%)
since 08/20/24
52-Week
36.92 +8.72%
on 11/19/24
70.13 -42.76%
on 02/27/24
-20.36 (-33.65%)
since 11/20/23

Most Recent Stories

More News
Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights

LEGN : 40.14 (+4.53%)
Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition

LEGN : 40.14 (+4.53%)
Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma

LEGN : 40.14 (+4.53%)
Legend Biotech Appoints Alan Bash as President of CARVYKTI®

LEGN : 40.14 (+4.53%)
Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results

LEGN : 40.14 (+4.53%)
Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia

LEGN : 40.14 (+4.53%)
Canadians Enjoy Shortened Week

Monday U.S. Economic Lookahead S&P final U.S. services PMI (July) ...

BABA : 86.77 (-0.39%)
VFS : 3.98 (-1.73%)
LEGN : 40.14 (+4.53%)
EVRG : 64.37 (+0.61%)
CSX : 34.57 (-0.09%)
CFF.TO : 0.3900 (+5.41%)
AMGN : 287.87 (+2.83%)
DIS : 114.26 (+1.64%)
SHOP : 103.94 (-0.62%)
MCK : 621.14 (+0.89%)
KBL.TO : 36.13 (+2.67%)
CAT : 381.50 (-0.22%)
Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike

/CNW/ -- USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of cancer...

ONCY : 0.9985 (-5.80%)
ONC.TO : 1.40 (-5.41%)
MBIO : 0.2090 (-5.30%)
LEGN : 40.14 (+4.53%)
JNJ : 153.11 (+0.07%)
NRIX : 22.64 (-0.66%)
Oncology Market Rising Towards $564.5B Amid Cancer Spike and Biotech Innovations

VANCOUVER – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of cancer cases in younger age groups than before....

ONCY : 0.9985 (-5.80%)
ONC.TO : 1.40 (-5.41%)
MBIO : 0.2090 (-5.30%)
LEGN : 40.14 (+4.53%)
JNJ : 153.11 (+0.07%)
NRIX : 22.64 (-0.66%)
Manufacturing, Housing Due Next Week in Canada

Monday U.S. Featured Earnings Legend Biotech Corporation (NASDAQ: LEGN) (Q1) EPS ...

CRDL.TO : 2.18 (-4.80%)
ORE.TO : 0.60 (+3.45%)
PBH.TO : 80.34 (-0.01%)
LEGN : 40.14 (+4.53%)
STNE : 9.11 (-1.83%)
PHVS : 20.50 (-0.05%)
BABA : 86.77 (-0.39%)
SONY : 19.18 (+1.37%)
CSCO : 57.50 (+0.86%)
TJX : 119.74 (+0.15%)
CPRT : 55.42 (-1.95%)
WMT : 87.18 (+0.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in...

See More

Key Turning Points

3rd Resistance Point 43.88
2nd Resistance Point 42.44
1st Resistance Point 41.29
Last Price 40.14
1st Support Level 38.70
2nd Support Level 37.26
3rd Support Level 36.11

See More

52-Week High 70.13
Fibonacci 61.8% 57.44
Fibonacci 50% 53.52
Fibonacci 38.2% 49.61
Last Price 40.14
52-Week Low 36.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar